ANCA vasculitis: To lump or split? Why we should study MPA and GPA separately

Rheumatology (United Kingdom)

Volumn 51, Issue 12, 2012, Pages 2115-2117

  Watts, Richard A ^a   Scott, David G I ^b  

^a IPSWICH HOSPITAL NHS TRUST   (United Kingdom)

^b UNIVERSITY OF EAST ANGLIA   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANCA ASSOCIATED VASCULITIS; CLINICAL STUDY; EDITORIAL; EOSINOPHILIC GRANULOMA; GENETIC ASSOCIATION; GENETIC DIFFERENCE; GENOTYPE; GRANULOMATOSIS; GRANULOMATOSIS WITH POLYANGIITIS; HUMAN; MICROSCOPIC POLYANGIITIS; OUTCOME ASSESSMENT; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM;

ANTIBODIES, ANTINEUTROPHIL CYTOPLASMIC; CHURG-STRAUSS SYNDROME; HUMANS; MICROSCOPIC POLYANGIITIS; WEGENER GRANULOMATOSIS; WORLD HEALTH;

EID: 84870331340     PISSN: 14620324     EISSN: 14620332     Source Type: Journal    
DOI: 10.1093/rheumatology/kes230     Document Type: Editorial

References (10)

1. Rasmussen N. The 2012 revised international Chapel Hill consensus conference nomenclature of the vasculitides. Ann Rheum Dis 2012;71(Suppl 3):16.
2. Watts RA, Mooney J, Skinner J, Scott DGI, MacGregor AJ. The contrasting epidemiology of granulomatosis with polyangiitis (Wegener's granulomatosis) and microscopic polyangiitis. Rheumatology 2012;51: 926-31.
3. Fujimoto S, Watts RA, Kobayashi S et al. Comparison of the epidemiology of anti-neutrophil cytoplasmic antibodyassociated vasculitis between Japan and the UK. Rheumatology 2011;50:1916_20.
4. Stegeman CA, Tervaert JW, Sluiter WJ et al. Association of chronic nasal carriage of Staphylococcus aureus and higher relapse rates in Wegener granulomatosis. Ann Intern Med 1994;120:12-7.
5. Chen M, Kallenberg C. The environment, geoepidemiology and ANCA-associated vasculitis. Autoimmun Rev 2010;9: A293-8.
6. Walsh M, Flossman O, Berdin A et al. Risk factors for relapse of antinneutrophil cytoplasmic antibody-associated vasculitis. Arthritis Rheum 2012;64:542-8.
7. Booth AD, Almond MK, Burns A et al. Outcome of ANCA-associated renal vasculitis: a 5-year retrospective study. Am J Kidney Dis 2003;41:776-84.
8. Lyons PA, Rayner TF, Trivedi S et al. Genetically distinct subsets within ANCA-associated vasculitis. N Engl J Med 2012;367:214-23.
9. Luisetti M, Seersholm N. Alpha1-antitrypsin deficiency-1: epidemiology of alpha1-antitrypsin deficiency. Thorax 2004;59:164-9.
10. Watts RA, Suppiah R, Merkel PA, Luqmani RA. Systemic vasculitis-is it time to reclassify? Rheumatology 2011;50: 643-5.